Guard Therapeutics International AB Net Asset Quality Index
Guard Therapeutics International AB net asset quality index. Guard Therapeutics International AB (GUARD) has a Net Asset Quality Index of 78.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr70.88 Million minus total liabilities of Skr15.24 Million yields net assets of Skr55.63 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Guard Therapeutics International AB for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guard Therapeutics International AB (2008–2024)
Net asset quality index of Guard Therapeutics International AB from 2008 to 2024. This chart shows how Guard Therapeutics International AB's Net Asset Quality Index has evolved across 16 annual periods from 2008 to 2024. As of September 2025, the index stands at 78.5%, representing net assets of Skr55.63 Million against total assets of Skr70.88 Million SEK. Check GUARD strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Guard Therapeutics International AB Net Asset Quality Index by Year (2008–2024)
Guard Therapeutics International AB net asset quality index by year from 2008 to 2024. The table below presents the year-by-year Net Asset Quality Index for Guard Therapeutics International AB from 2008 to 2024, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Guard Therapeutics International AB.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.1% | Skr37.97 Million | Skr55.74 Million | Skr17.77 Million | ▼ -10.2 pp |
| 2023 | 78.3% | Skr66.73 Million | Skr85.23 Million | Skr18.49 Million | ▼ -9.2 pp |
| 2022 | 87.5% | Skr177.36 Million | Skr202.60 Million | Skr25.24 Million | ▼ -4.8 pp |
| 2021 | 92.3% | Skr175.78 Million | Skr190.44 Million | Skr14.66 Million | ▲ +4.9 pp |
| 2020 | 87.4% | Skr79.69 Million | Skr91.22 Million | Skr11.54 Million | ▲ +4.8 pp |
| 2019 | 82.6% | Skr52.62 Million | Skr63.71 Million | Skr11.09 Million | ▲ +93.4 pp |
| 2018 | -10.8% | Skr-2.94 Million | Skr27.28 Million | Skr30.21 Million | ▼ -84.0 pp |
| 2017 | 73.2% | Skr31.96 Million | Skr43.65 Million | Skr11.68 Million | ▲ +1.8 pp |
| 2016 | 71.4% | Skr30.34 Million | Skr42.47 Million | Skr12.13 Million | ▼ -11.1 pp |
| 2015 | 82.6% | Skr42.69 Million | Skr51.69 Million | Skr9.00 Million | ▼ -7.6 pp |
| 2014 | 90.1% | Skr52.25 Million | Skr57.97 Million | Skr5.71 Million | ▲ +36.3 pp |
| 2013 | 53.9% | Skr25.42 Million | Skr47.17 Million | Skr21.75 Million | ▼ -10.1 pp |
| 2012 | 63.9% | Skr30.58 Million | Skr47.82 Million | Skr17.25 Million | ▲ +36.7 pp |
| 2011 | 27.2% | Skr2.12 Million | Skr7.78 Million | Skr5.66 Million | ▼ -50.7 pp |
| 2010 | 78.0% | Skr3.08 Million | Skr3.96 Million | Skr871.82K | ▼ -10.7 pp |
| 2008 | 88.7% | Skr2.34 Million | Skr2.64 Million | Skr299.00K | — |